(19)
(11) EP 0 828 712 A1

(12)

(43) Date of publication:
18.03.1998 Bulletin 1998/12

(21) Application number: 95915993.0

(22) Date of filing: 10.05.1995
(51) International Patent Classification (IPC): 
C07D( . )
A61K 31/ 44( . )
A61P 1/ 14( . )
A61P 3/ 06( . )
A61P 3/ 10( . )
A61P 13/ 02( . )
A61P 25/ 24( . )
C07D 213/ 73( . )
C07D 487/ 04( . )
C07D 239/ 42( . )
A23K 1/ 16( . )
A61K 31/ 505( . )
A61P 3/ 00( . )
A61P 3/ 08( . )
A61P 11/ 00( . )
A61P 15/ 00( . )
A61P 25/ 26( . )
C07D 213/ 74( . )
C07F 7/ 10( . )
(86) International application number:
PCT/IB1995/000342
(87) International publication number:
WO 1996/035670 (14.11.1996 Gazette 1996/50)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(71) Applicant: PFIZER INC.
New York, N.Y. 10017 (US)

(72) Inventor:
  • DOW, Robert, L.
    Waterford, CT 06385 (US)

(74) Representative: Ruddock, Keith Stephen, et al 
Pfizer Limited, European Patent Department, Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) BETA-ADRENERGIC AGONISTS